VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of $7.17 million. The enterprise value is $1.27 million.
Important Dates
The next estimated earnings date is Wednesday, February 18, 2026, before market open.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VivoSim Labs has 2.61 million shares outstanding. The number of shares has increased by 90.82% in one year.
| Current Share Class | 2.61M |
| Shares Outstanding | 2.61M |
| Shares Change (YoY) | +90.82% |
| Shares Change (QoQ) | +4.04% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 8.01% |
| Float | 2.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 35.76 |
| Forward PS | 65.03 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.10, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.10 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -869.43 |
Financial Efficiency
Return on equity (ROE) is -36.91% and return on invested capital (ROIC) is -117.31%.
| Return on Equity (ROE) | -36.91% |
| Return on Assets (ROA) | -92.55% |
| Return on Invested Capital (ROIC) | -117.31% |
| Return on Capital Employed (ROCE) | -168.19% |
| Weighted Average Cost of Capital (WACC) | 9.46% |
| Revenue Per Employee | $10,769 |
| Profits Per Employee | -$152,538 |
| Employee Count | 13 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VivoSim Labs has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.61% in the last 52 weeks. The beta is 1.18, so VivoSim Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -36.61% |
| 50-Day Moving Average | 2.09 |
| 200-Day Moving Average | 2.20 |
| Relative Strength Index (RSI) | 63.12 |
| Average Volume (20 Days) | 4,818,540 |
Short Selling Information
The latest short interest is 8,396, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 8,396 |
| Short Previous Month | 11,105 |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.33% |
| Short Ratio (days to cover) | 0.83 |
Income Statement
In the last 12 months, VivoSim Labs had revenue of $140,000 and -$1.98 million in losses. Loss per share was -$0.96.
| Revenue | 140,000 |
| Gross Profit | -4.43M |
| Operating Income | -12.17M |
| Pretax Income | -1.98M |
| Net Income | -1.98M |
| EBITDA | -11.92M |
| EBIT | -12.17M |
| Loss Per Share | -$0.96 |
Full Income StatementBalance Sheet
The company has $6.68 million in cash and $1.05 million in debt, with a net cash position of $5.63 million or $2.16 per share.
| Cash & Cash Equivalents | 6.68M |
| Total Debt | 1.05M |
| Net Cash | 5.63M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 7.07M |
| Book Value Per Share | 2.71 |
| Working Capital | 5.14M |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.15M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.15M |
| FCF Per Share | -$3.89 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -8,694.29% |
| Pretax Margin | -1,415.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -90.82% |
| Shareholder Yield | -90.82% |
| Earnings Yield | -28.75% |
| FCF Yield | -147.20% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 21, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
VivoSim Labs has an Altman Z-Score of -52.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -52.4 |
| Piotroski F-Score | 3 |
